Market Research, Market Size, Market Research Report, Market Share, Market Analysis, Market Growth,

Showing posts with label Regenerative Medicine. Show all posts
Showing posts with label Regenerative Medicine. Show all posts

Monday, March 14, 2022

Growth Of Collagen & Gelatin Market for Regenerative Medicine

According to the new market research report “Collagen and Gelatin Market by Source (Bovine, Porcine, Marine), Application (Wound Care, Orthopedic, Cardiovascular Disease, Dental, Surgical, Dural), End User (Hospitals, Surgical Centers) and Region – Global Forecast to 2026″, published by MarketsandMarkets™, the global bovine collagen market is projected to reach 1,083 million by 2026 from USD 772 million in 2021, at a CAGR of 7.0% during the forecast period.

OPPORTUNITY: Implementation of the 21st Century Cures Act;

The 21st Century Cures Act was signed into law in the US in December 2016. The Act is designed to help accelerate medical product development and bring innovations and advances to patients who need them faster and efficiently. Under this Act, a new Regenerative Medicine Advanced Therapy designation has been established, along with a fast-track approval pathway for new regenerative medicine products. Considering this, the implementation of this Act can potentially result in the approval of new regenerative medicine products in the US and stimulate R&D in the field of regenerative medicine.

Download PDF Brochurehttps://www.marketsandmarkets.com/pdfdownloadNew.asp?id=95663122

Collagen & Gelatin Market


The Growth in the collagen and gelatin market is driven by factors such as the rising prevalence of target diseases and disorders, rising number of surgeries coupled with growing geriatric population, and investments in R&D. However, the availability of efficient and reliable substitute biomaterials is expected to restrain the market growth during the forecast period.

The bovine segment accounted for the largest share of the source segment in the collagen and gelatin market in 2020.

Based on source, the market is segmented into bovine, porcine, and others. The bovine source segment accounted for the largest share of both the collagen market and the gelatin market in 2020. This growth can be attributed to its increased usage in regenerative medicine owing to its high biocompatibility and biodegradability.

The orthopedic segment accounted for the largest share of the application segment in the gelatin market in 2020

Based on application, the global collagen market is segmented into orthopedic, wound care, dental, surgical, cardiovascular, and other applications. The global gelatin market is segmented into orthopedic, wound care, and others. The orthopedic segment accounted for the largest share of both the collagen market and the gelatin market in 2020, mainly due to the increasing use of these biomaterials in orthopedic surgeries and the high demand for scaffolds for bone substitutes.

Request Sample Pageshttps://www.marketsandmarkets.com/requestsampleNew.asp?id=95663122

The Asia Pacific region is the fastest-growing region of the collagen market in 2020.

The collagen and gelatin market in the Asia Pacific region is expected to grow at the highest CAGR during the forecast period. Growth in the APAC market is driven by rising geriatric population in Japan and China, increasing prevalence of chronic wounds, and growth in the number of people suffering from pressure ulcers.

Key players in the collagen and gelatin market include Integra LifeSciences (US), Royal DSM (Netherlands), CollPlant Biotechnologies (Israel), Nitta Gelatin Inc. (Japan), Collagen Solutions plc (UK), Collagen Matrix, Inc. (US), Symatese (France), GELITA AG (Germany), PB Leiner (Belgium), Smith & Nephew (UK), Zimmer Biomet (US).

Speak to Analysthttps://www.marketsandmarkets.com/speaktoanalystNew.asp?id=95663122

Friday, January 28, 2022

Regenerative Medicine Market Size, Share, Outlook, Industry Analysis Report 2020

The Research Report on "Regenerative Medicine Market by Product (Cell Therapies (Autologous, Allogenic), Stemcell Therapy, Tissue-engineering, Gene Therapy), Application (Wound Care, Musculoskeletal, Oncology, Dental, Ocular), Geography - Global Forecast to 2025", is projected to reach USD 17.9 billion by 2025 from USD 8.5 billion in 2020, at a CAGR of 15.9%.

Growth Driver: Growing prevalence of chronic diseases, genetic disorders, and cancer;

Over the last few decades, the incidence and prevalence of chronic diseases such as CVD, cancer, diabetes, ulcers, and genetic disorders such as cystic fibrosis have increased significantly across the globe. Diabetes and obesity can result in the increased incidence and complexity of wounds such as infections, ulcerations (leg or foot ulcers), and surgical wounds, which require treatments and incur exorbitant medical expenses.

Growth Opportunity: Implementation of the 21st Century Cures Act;

The 21st Century Cures Act was signed into law in the US in December 2016. Among other objectives, this new law has been enacted to advance regenerative medicine research and medical innovation and covers various provisions that may impact the development and approval of several products in the coming years.

Download PDF Brochurehttps://www.marketsandmarkets.com/pdfdownloadNew.asp?id=65442579

Regenerative Medicine Market

Industry Segmentation In Detailed:

The tissue-engineered products segment accounted for the largest share of the regenerative medicine market, by product segment, in 2019

Based on products, segmented into tissue-engineered products, cell therapies, gene therapies, and progenitor and stem cell therapies. The tissue-engineered products segment accounted for the largest share in the regenerative medicine market in 2019. The increasing adoption of tissue-engineered products for the treatment of chronic wounds and musculoskeletal disorders and the rising funding for the R&D of regenerative medicine products and therapies are the major factors driving the growth of this segment.

Oncology segment to register the highest growth rate during the forecast period

Based on applications, the regenerative medicine market is segmented into musculoskeletal disorders, wound care, oncology, ocular disorders, dental, and other applications. In 2019, the oncology segment accounted for the highest growth rate. This can be attributed to the rising prevalence of orthopedic diseases, growing geriatric population, increasing number of stem cell research projects, growing number of clinical researches/trials, and the rich pipeline of stem cell products for the treatment of musculoskeletal disorders.

Request Sample Pageshttps://www.marketsandmarkets.com/requestsampleNew.asp?id=65442579

Leading Key Players and Analysis:

The major players operating in Regenerative Medicine Market are 3M (US), Allergan plc (Ireland), Amgen, Inc. (US), Aspect Biosystems (Canada), bluebird bio (US), Kite Pharma (US), Integra LifeSciences Holdings Corporation (US), MEDIPOST Co., Ltd. (South Korea), Medtronic plc (Ireland), Anterogen Co., Ltd. (South Korea), MiMedx Group (US), Misonix (US), Novartis AG (Switzerland), Organogenesis Inc. (US), Orthocell Limited (Australia), Corestem, Inc. (South Korea), Spark Therapeutics (US), APAC Biotech (India).

Novartis AG (Switzerland) Novartis AG is one of the the largest player in the regeneartive medicine market in 2019. In order to maintain its position in the market, the company has been focusing on the innovations, and breakthrough product approvals for the treatment of cancer. For instance, in August 2017, Novartis received the FDA approval for CAR-T cell therapy, Kymriah (CTL019), which is used for the treatment of cancer. Kymriah got the EU approval in August 2018. Novartis also focused on the inorganic strategies in order to enhance their dominance in the regenerative medicine market. For instance, Novartis received EU approval for one-time gene therapy, Luxturna, developed by Spark Therapeutics, to restore vision in people with rare and genetically-associated retinal disease.

Geographical Analysis in Detailed:

The regenerative medicine market is segmented into four major regions, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). In 2019, North America accounted for the largest share in the market. The growth in the North American market can be attributed to rising stem cell banking, tissue engineering, and drug discovery in the region; expansion of the healthcare sector; and the high adoption of stem cell therapy and cell immunotherapies for the treatment of cancer and chronic diseases.

Speak to Analysthttps://www.marketsandmarkets.com/speaktoanalystNew.asp?id=65442579

Thursday, April 25, 2019

Growth Opportunities in Regenerative Medicine Market

The Global Regenerative Medicine Market is projected to reach USD 38.7 billion by 2024 from USD 13.3 billion in 2019, at a CAGR of 23.8%.
Market growth is largely driven by the rising prevalence of chronic diseases and genetic disorders, growing government investments in regenerative medicine research, and the increasing number of regenerative medicine companies globally.
Growth in this market is largely driven by the introduction of Cures Act for regenerative medicine by FDA, increased funding for regenerative medicine research, development of CAR-T cell therapies and increasing demand for regenerative medicine for the treatment of cancer, orthopedic disorders, and chronic wounds among others.
Regenerative Medicine Market segmentation:
· based on the type
· based on application
· based on regions
The Major Players Operating in the Regenerative Medicine Market:
The major players in this market are Kite Pharma (US), Novartis (Switzerland), Vericel Corporation (US), Integra LifeSciences (US), Wright Medical (US), MiMedx (US), Osiris Therapeutics (US), Stryker Corporation (US), and Spark Therapeutics (US). Product launches and acquisitions are the key growth strategies followed by most players in this market.
Regenerative Medicine Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the regenerative medicine market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
  • The key players in the industry and markets have been identified through extensive secondary research
  • The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes
  • All percentage share, splits, and breakdowns have been determined using secondary sources and verified through primary sources
Geographical Detailed Analysis for Regenerative Medicine Market:
North America anticipated accounting for the largest share of the market in 2019.
The regenerative medicine market in North America is expected to account for the largest share globally and grow at a faster rate during the forecast period. Surging research activities in the field of regenerative medicine, the introduction of CAR-T cell therapies and growing awareness of personalized medicine have also resulted in the establishment of stem cell banking and tissue engineering.

Friday, March 8, 2019

Rising Opportunities in the Emerging Markets to Boost the Growth of the Regenerative Medicine Market

The report Regenerative Medicine Market by Therapy (Cell Therapy, Tissue Engineering, Immunotherapy, Gene Therapy), Product (Cell-Based, Acellular), Applications (Orthopedic & Musculoskeletal Disorders, Dermatology, Oncology, Cardiology) — Forecast to 2021”, report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the Regenerative Medicine Market along with the estimates and forecasts of the revenue and market share analysis.
The Global Regenerative Medicine Market is expected to reach the US $38.70 Billion, at a CAGR of 23.6%. The major factor driving the growth of this market, our government and private funding to support the development of regenerative medicine, the rising prevalence of chronic diseases and genetic disorders, increase in global healthcare expenditure, and rapid growth in the aging population.
Download PDF Brochure (Regenerative Medicines Market):https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=65442579
The report segments this market based on types, therapy, application, and regions.
Ethical concerns with the use of embryonic stem cell for R&D is a major factor restraining the growth of the market. Research in regenerative medicine necessitates the use of animals and humans in gene therapy studies that involve the recombination of genes and stem cell research therapies. These cells are also used for in vivo toxicity and pharmacokinetic testing of drugs that may harm animals and humans. In addition, stem cell research studies use human embryos for clinical applications that often lead to the destruction of the embryos.
Regenerative Medicine Market Dynamics:
Market Drivers:
  • Government & Private Funding to Support the Development of Regenerative Medicine
  • Rising Prevalence of Chronic Diseases and Genetic Disorders
  • Increase in Global Healthcare Expenditure
  • Rapid Growth in the Aging Population
  • Increase in Corporate Partnerships to Accelerate Development and Commercialization of Regenerative Medicine
Market Restraints:
  • Ethical Concerns with the Use of Embryonic Stem Cell for R&D
  • Lack of Clear Regulatory Guidelines
Market Opportunities:
  • Rising Demand for Organ Transplantation
  • Strong Product Pipeline
By application, orthopedic & musculoskeletal disorders, dermatology, cardiology, diabetes, central nervous system diseases, and other applications. Oncology is expected to account the fastest growing market owing to increasing prevalence of cancer globally and rich product pipeline and increasing demand for cancer treatments.
Browse 87 market data tables and 38 figures spread through 137 pages and in-depth TOC on “Regenerative Medicine Market”
 https://www.marketsandmarkets.com/Market-Reports/regenerative-medicine-market-65442579.html
Based on regions, the global Regenerative Medicine Market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). North America is expected to account for the largest share of the market during the forecast period. Growth in this regional segment is driven by factors such as technological advancement in the Regenerative medicine and rising incidences of chronic diseases and aging population.
Key players in the Regenerative Medicine Market include Organogenesis Inc. (U.S.), Osiris Therapeutics, Inc. (U.S.), Vericel Corporation (U.S.), Stryker Corporation (U.S.), and NuVasive, Inc. (U.S.), Medtronic (Ireland), Acelity (KCI Concepts) (U.S.), Integra LifeSciences (U.S.), Cook Biotech Inc. (U.S.), and C.R. Bard (U.S.).

Thursday, February 14, 2019

Global Regenerative Medicine Market Trends and Industry Analysis Report

The Research Report Consist of 137 pages, which covers Global Regenerative Medicine Market overview, Major Key Players detailed Analysis, market opportunities, market risk, forecast for the next five years, major driving factors for the market as well as detailed analysis for CAGR, scope, research findings, leading key players marketing strategy to acquire major market in the form of revenue.
Also, the Research report on Regenerative Medicine Market covers key statistics for the upcoming forecast year. This Research Report is a big source for the guidance to business leaders, strategy heads.
The cell-based products are expected to dominate the Global Regenerative Medicine Market. Increasing funding from several agencies and private organizations for the research and development of cell therapies, a growing inclination of the healthcare industry towards stem cell research and increasing global awareness about the benefits of stem cell therapies are driving the growth of the cell therapy segment.
Download PDF (Regenerative Medicine):
Market Dynamics — Regenerative Medicine Market
Market Drivers:
  • Government & Private Funding to Support the Development of Regenerative Medicine
  • Rising Prevalence of Chronic Diseases and Genetic Disorders
  • Increase in Global Healthcare Expenditure
  • Rapid Growth in the Aging Population
  • Increase in Corporate Partnerships to Accelerate Development and Commercialization of Regenerative Medicine Market.
Market Restraints:
  • Ethical Concerns with the Use of Embryonic Stem Cell for R&D
  • Lack of Clear Regulatory Guidelines
Orthopedic & Musculoskeletal Disorders, Dermatology, Cardiology, Central Nervous System Diseases will drive the growth of regenerative medicine market
Orthopedic & Musculoskeletal Disorders-
The increasing prevalence of orthopedic diseases, rising aging population, increasing number of stem cell research projects and the rich pipeline of stem cell products for the treatment of musculoskeletal disorders under both autologous and allogeneic cell therapies are the key drivers for the growth of this Regenerative Medicine Market.
Dermatology-
In dermatology, Regenerative Medicine is majorly used for tissue regeneration and healing of burns and chronic wounds. The treatment of burns and chronic wounds requires a speedy response, where skin grafting is required in most of the cases. Regenerative medicine helps in reducing the after-effects of general treatments which are carried out for burns, including scars and other skin infections.
Read More in Detailed (Regenerative Medicine Market):

Wednesday, February 6, 2019

Regenerative Medicine Market size, Analysis by Trend and Forecast

[137 Pages Report] The Regenerative Medicine Market is expected to reach $38.70 billion, at a CAGR of 23.6%.
The research report provides a detailed overview of the major drivers, restraints, challenges, opportunities, current market trends, and strategies impacting the Regenerative Medicine Market along with the estimates and forecasts of the revenue and market share analysis.


Orthopedic & Musculoskeletal Disorders, Dermatology, Cardiology, Central Nervous System Diseases will drive the growth of Regenerative Medicine Market.
Dermatology:
In dermatology, regenerative medicine is majorly used for tissue regeneration and healing of burns and chronic wounds. The treatment of burns and chronic wounds requires a speedy response, where skin grafting is required in most of the cases. Regenerative medicine helps in reducing the after-effects of general treatments which are carried out for burns, including scars and other skin infections.
Increasing funding from several agencies and private organizations for the research and development of cell therapies, the growing inclination of the healthcare industry towards stem cell research and increasing global awareness about the benefits of stem cell therapies are driving the growth of the cell therapy segment.
Regenerative Medicine Market segmentation:
· based on type.
· based on application.
· based on therapy.
· based on region.
The Major Players Operating in the Regenerative Medicine Market:
The company’s focus on product launches, acquisitions, and agreements to enhance its product portfolio are the Key Strategies Adopted by Leading Market Players to Foster Growth in the Global Regenerative Medicine Market.
Key players in the Regenerative Medicine Market include Organogenesis Inc. (U.S.), Osiris Therapeutics, Inc. (U.S.), Vericel Corporation (U.S.), Stryker Corporation (U.S.), and NuVasive, Inc. (U.S.), Medtronic (Ireland), Acelity (KCI Concepts) (U.S.), Integra LifeSciences (U.S.), Cook Biotech Inc. (U.S.), and C.R. Bard (U.S.).
Geographical Detailed Analysis for Regenerative Medicine Market:
The global Regenerative Medicine Market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW).
North America is expected to account for the largest share of the market during the forecast period.
Growth in this regional segment is driven by factors such as technological advancement in Regenerative Medicine and rising incidences of chronic diseases and aging population.
Read More in Detailed (Regenerative Medicine):

Tuesday, November 13, 2018

Regenerative Medicine Market Size, Share, Growth, Trend and Forecast

[137 Pages Report] The Regenerative Medicine Market is expected to reach USD 38.70 billion by 2021 from USD 13.41 billion in 2016 at a CAGR of 23.6%. 

The cell-based products are expected to dominate the global Regenerative Medicine Market.

Don’t miss out on business opportunities in Regenerative Medicine Market.


Increasing funding from several agencies and private organizations for the research and development of cell therapies, growing inclination of the healthcare industry towards stem cell research, and increasing global awareness about the benefits of stem cell therapies are driving the growth of the cell therapy segment.
Speak to our analyst and gain crucial industry insights that will help your business grow: https://www.marketsandmarkets.com/speaktoanalyst.asp?id=65442579
The major factor driving the growth of this market, our government and private funding to support the development of regenerative medicine, rising prevalence of chronic diseases and genetic disorders, increase in global healthcare expenditure, and rapid growth in the aging population.
Browse and in-depth TOC on “Regenerative Medicine Market”
87 — Tables
38 — Figures
137 — Pages
View more detailed TOC @
Based on therapy, the Regenerative Medicine Market is segmented into cell therapy, gene therapy, tissue engineering, and immunotherapy. The cell therapy segment is expected to account for the largest share of this market, increasing funding from several agencies and private organizations for the research and development of cell therapies, growing inclination of the healthcare industry towards stem cell research, and increasing global awareness about the benefits of stem cell therapies.
By application, orthopedic & musculoskeletal disorders, dermatology, cardiology, diabetes, central nervous system diseases, and other applications. Oncology is expected to account the fastest growing market owing to increasing prevalence of cancer globally and rich product pipeline and increasing demand for cancer treatments.
Request for Free Sample Report @
Based on regions, the global Regenerative Medicine Market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World (RoW). North America is expected to account for the largest share of the market during the forecast period. Growth in this regional segment is driven by factors such as technological advancement in the Regenerative medicine and rising incidences of chronic diseases and aging population.
Key players in the Regenerative Medicine Market include Organogenesis Inc. (U.S.), Osiris Therapeutics, Inc. (U.S.), Vericel Corporation (U.S.), Stryker Corporation (U.S.), and NuVasive, Inc. (U.S.), Medtronic (Ireland), Acelity (KCI Concepts) (U.S.), Integra LifeSciences (U.S.), Cook Biotech Inc. (U.S.), and C.R. Bard (U.S.).
Browse Adjacent Markets @ Biotechnology Market Research Reports & Consulting
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model — GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact Us:
 
Mr. Shelly Singh
 MarketsandMarkets™ INC.
 630 Dundee Road
 Suite 430
 Northbrook, IL 60062
 USA: +1–888–600–6441
 Email: sales@marketsandmarkets.com